The Cutting Edge of Medical Technology Content, Community & Collaboration
Setting up aSection 8 Microfinance Company in India is an excellent way to offer small loans to low-income groups and promote financial inclusion with a not-for-profit approach. Section 8 companies are registered under the Companies Act, 2013 with the objective of promoting charitable activities, including microfinance services such as lending, financial literacy, and poverty alleviation.
Unlike NBFCs, Section 8 microfinance companies do not require RBI approval, making the registration process more streamlined and cost-effective. However, compliance and documentation requirements must be followed strictly, including the drafting of MOA, AOA, and financial projections, among other legal formalities.
This is where Agile Regulatory steps in to make the process simple and stress-free. We are a trusted partner for entrepreneurs looking to start microfinance institutions under Section 8 structure. Our experts handle the entire process, including company name approval, preparation and filing of incorporation documents, drafting objectives related to microfinance, and applying for Section 8 license from the MCA (Ministry of Corporate Affairs).
We also help with PAN, TAN, bank account opening, and other post-registration formalities to ensure you are ready to operate. Whether you want to run a loan business for SHGs, rural women, or low-income individuals, Agile Regulatory provides all the necessary legal and technical assistance for quick setup.
With years of experience in NGO and finance sector registrations, Agile Regulatory ensures your application complies with MCA norms and is approved in the shortest time possible. Our team is always available to resolve doubts, guide through government portals, and help you meet annual compliance requirements.
If you’re planning to start a Section 8 Microfinance Company, contact Agile Regulatory today. We’ll help you take the first step toward empowering lives—legally and professionally.
© 2026 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
You need to be a member of MedTech I.Q. to add comments!
Join MedTech I.Q.